The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Benetor 40 mg film-coated tablets



Daiichi Sankyo Ireland LtdPA1595/001/003

Main Information

Trade NameBenetor 40 mg film-coated tablets
Active SubstancesOlmesartan medoxomil
Dosage FormFilm-coated tablet
Licence HolderDaiichi Sankyo Ireland Ltd
Licence NumberPA1595/001/003

Group Information

ATC CodeC09CA Angiotensin II antagonists, plain
C09CA08 olmesartan medoxomil

Status

License statusWithdrawn
Withdrawn Date01/10/2023
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available

Generics Information

Interchangeable List CodeIC0105-004-003
Interchangeable List DocumentPDF of Interchangeable List
« Back